These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 208736)

  • 21. Protective immunity in equine herpesvirus type I infection of hamsters.
    Wilks CR; Coggins L
    Cornell Vet; 1977 Jul; 67(3):385-403. PubMed ID: 194753
    [No Abstract]   [Full Text] [Related]  

  • 22. Equine rhinopneumonitis vaccine: immunogenicity and safety in adult horses, including pregnant mares.
    Purdy CW; Ford SJ; Porter RC
    Am J Vet Res; 1978 Mar; 39(3):377-83. PubMed ID: 205144
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
    Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
    Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters.
    Burek JD; Roos RP; Narayan O
    Lab Invest; 1975 Oct; 33(4):400-6. PubMed ID: 171478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic transformation by equine herpesviruses (EHV). I. Properties of hamster embryo cells transformed by ultraviolet-irradiated EHV-1.
    Robinson RA; Henry BE; Duff RG; O'Callaghan DJ
    Virology; 1980 Mar; 101(2):335-62. PubMed ID: 6244694
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
    Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
    Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
    Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
    Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic comparisons between herpesviruses isolated from fallow deer in Alberta and the viruses of infectious bovine rhinotracheitis, equine rhinopneumonitis and DN-599, a non-IBR bovine herpesvirus.
    Kinyili JH; Thorsen J
    J Wildl Dis; 1979 Apr; 15(2):339-41. PubMed ID: 225575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of pseudorabies virus serotests.
    Neill JD; Kelling CL; Rhodes MB
    Am J Vet Res; 1984 Dec; 45(12):2675-6. PubMed ID: 6098206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against diseases associated with herpesvirus infections in animals: a review.
    Plowright W
    IARC Sci Publ (1971); 1978; (24 Pt 2):965-80. PubMed ID: 221416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of equine herpesvirus type 1 (EHV1) and equine rhinovirus type 1 (ERhV1) following inactivation by betapropiolactone (BPL) and ultraviolet (UV) light.
    Campbell TM; Studdert MJ; Blackney MH
    Vet Microbiol; 1982 Dec; 7(6):535-44. PubMed ID: 6301141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against herpesvirus, fiction or reality?
    Morein B; Merza M
    Scand J Infect Dis Suppl; 1991; 80():110-8. PubMed ID: 1666442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 40. Structural proteins of equine infectious anemia virus and their antigenic activity.
    Nishimura M; Nakajima H
    Am J Vet Res; 1984 Jan; 45(1):5-10. PubMed ID: 6322625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.